Skip to main content
AGTX
OTC Life Sciences

Agentix Corp. Reports $0 Revenue, $486K Net Loss for FY26

Reported by Wiseek News
Sentiment info
Negative
Importance info
7
Price
$0.02
Mkt Cap
$801.339K
52W Low
$0.014
52W High
$0.839
52W Position info
41% above low
Off High info
98% below high
Rel. Volume info
8.6× avg
Market data snapshot near publication time

AGTX sits 41% above its 52-week low of $0.014 on elevated volume (8.6× avg).

Summary

Agentix Corp. reported $0 revenue and a net loss of $486,000 for fiscal year 2026, with diluted EPS at $(0.01). While the net loss narrowed slightly from the prior year, the company continues to generate no commercial revenue. This annual report confirms the ongoing financial challenges, following the previous 10-Q that raised substantial doubt about its ability to continue as a going concern. Management is actively pursuing new financing to fund operations and development.

At the time of this announcement, AGTX was trading at $0.02 on OTC in the Life Sciences sector, with a market capitalization of approximately $801.3K. The 52-week trading range was $0.01 to $0.84. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

AGTX - Latest Insights

AGTX
Jul 01, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.020
Real-time Price: $0.020 info
Change: $0 (0%) info
Market Cap: $801.339K info
AGTX
Jun 30, 2026, 7:36 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.020
Real-time Price: $0.020 info
Change: $0 (0%) info
Market Cap: $801.339K info
AGTX
Feb 17, 2026, 1:26 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.04198
Real-time Price: $0.020 info
Change: -$0.02198 (-52%) info
Market Cap: $801.339K info